About INCLUSIVE study
BACKGROUND The fixed-dose combination pills are recommended from the international guide lines, both because they are very standardized and for the best compliance of the patients, that do not like to assume pills: a greater therapeutic success means less complications and therefore, in last analysi...
Main Author: | G. Pinna |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2013-05-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/336 |
Similar Items
-
Observational study on patients’ compliance with Irbesartan in essential hypertension “I Comply”
by: K. Leon, et al.
Published: (2014-03-01) -
IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01) -
Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey
by: U Tebbe, et al.
Published: (2009-08-01) -
Efficiency assessment for antihypertensive, hemodynamic, renal effects of adenosine-converting enzyme (ACE) inhibitors and irbesartan and impact on endothelial disfunction in patients with stage II hypertension
by: M. V. Pereviazkina
Published: (2014-08-01) -
Med-arb, arb-med y arb-med-arb a la luz de la legislación Ecuatoriana
by: Ana Isabel Cobo Ordóñez, et al.
Published: (2018-09-01)